At the Massachusetts General Hospital Fireman Vascular Center, our world-renowned research advances patient care in the field of renal and mesenteric artery disease.

Advancing Vascular Care

Clinical research in the Renal and Mesenteric Artery Disease Program at the Massachusetts General Hospital Fireman Vascular Center combines leading research with patient care to develop innovative options to treat renal and mesenteric artery disease.

View a sample of our clinical research below.

ARTISAN: iCAST™ RX De Novo Stent Placement for the Treatment of Atherosclerotic Renal Artery Stenosis in Patients with Resistant Hypertension

  • Description of study: The primary objective of the ARTISAN trial is to evaluate the safety and efficacy of the iCAST™ RX Stent System for the treatment of subjects with resistant hypertension associated with de novo atherosclerotic renal artery disease.
  • Study type: Clinical Trial
  • Principal Investigator: Douglas Drachman, MD